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Abstract. In light of future pharmacological interventions, neuroimaging markers able to assess the response to treatment
would be crucial. InGranulin (GRN) disease, preclinical data will prompt pharmacological trials in the future. Two main points
need to be assessed: 1) to identify target regions in different disease stages and 2) to determine the most accurate functional and
structural neuroimaging index to be used. To this aim, we have taken advantage of the multivariate approach of multi-voxel
pattern analysis (MVPA) to explore the information of brain activity patterns in a cohort of GRN Thr272fs carriers at different
disease stages (14 frontotemporal dementia (FTD) patients and 17 asymptomatic carriers) and a group of 33 healthy controls.
We studied structural changes by voxel-based morphometry (VBM), functional connectivity by assessing salience, default
mode, fronto-parietal, dorsal attentional, executive networks, and local connectivity by regional homogeneity, amplitude of
low frequency fluctuations (ALFF), fractional ALFF (fALFF), degree centrality, and voxel-mirrored homotopic connectivity.
In FTD patients with GRN mutation, the most predictive measure was VBM structural analysis, while in asymptomatic carriers
the best predictor marker was the local connectivity measure (fALFF). Altogether, all indexes demonstrated fronto-temporo-
parietal damage in GRN pathology, with widespread structural damage of fronto-parietal and temporal regions when disease
is overt. MVPA could be of aid in identifying the most accurate neuroimaging marker for clinical trials. This approach was
able to identify both the target region and the best neuroimaging approach, which would be specific in the different disease
stages. Further studies are needed to simultaneously integrate multimodal indexes in a classifier able to trace the disease
progression moving from preclinical to clinical stage of the disease.
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INTRODUCTION
Frontotemporal lobar degeneration (FTLD) is an
heterogeneous group of diseases characterized by
prominent frontal and behavioral features [1, 2].
Different clinical phenotypes have been described,
i.e., the behavioral variant frontotemporal dementia
(bvFTD), the agrammatic variant of primary pro-
gressive aphasia (avPPA), and the semantic variant
of PPA (svPPA) [1, 2]. For each clinical phenotype,
specific neuroimaging patterns have been identified
[3, 4]. Neuropathologically, in most of cases, fron-
totemporal dementia (FTD) is characterized by either
Tau (FTLD-Tau) or TAR-DNA-binding protein-43
(TDP-43) (FTLD-TDP) inclusions [5]. In the last two
decades, a number of autosomal dominant causative
mutations, such as mutations withinMicrotuble Asso-
ciated Protein Tau (MAPT) and Granulin (GRN)
along with repeat expansion of C9orf72 gene [6, 7]
have been described.
In particular, in GRN mutation cases, clinical pre-
sentation can be heterogeneous, ranging from typical
bvFTD to avPPA, but also with some cases resam-
pling corticobasal syndrome [8]. From this point
of view, if the asymmetric fronto-temporo-parietal
atrophy and functional impairment within salience
network and fronto-parietal network have been
defined [8, 9], neuroimaging pattern of alteration can
be quite different considering the different clinical
phenotypes of GRN mutations [10]. Multivariate sta-
tistical approach (like multi-voxel pattern analysis,
MVPA) to neuroimaging data has received increasing
attention, allowing the possibility to explore corre-
lation/covariance pattern of activation between brain
regions with greater statistical power, overcoming the
classical univariate statistical inference of voxel-by-
voxel analysis, by stringent correction for voxelwise
multiple comparisons [11]. MVPA [12, 13] repre-
sents a promising approach to study the information
that is represented in different patterns of neural
activity, through the application of an automated
classifier (i.e., support vector machine, SVM) [14]
to capture the complex relationships among spatial
pattern of brain activity in the studied populations
[15]. From this perspective, monogenic FTD repre-
sents a privileged point of view to test the potential
role of disease-modifying therapies, as cases with
known neuropathology and following the continuum
from presymptomatic to symtomatic stages [16, 17].
As recently demonstrated by GENFI initiative [17],
GRN carriers are characterized by insular and pari-
etal structural alteration up to 15 years before the
clinical onset, supporting the pivotal role of specific
preclinical biomarker to trace neurodegenerative dis-
eases like FTD and AD [18]. In light of future disease
modifying therapies, neuroimaging markers able to
assess the response would be key [17], with the ideal
marker should respond not only to the region that
needs to be investigated, but also in which way. In the
present work, we applied the multivariate approach
of MVPA to different magnetic resonance imaging
(MRI) metrics to study GRN-related disease (asymp-
tomatic subjects carrying GRN Thr272fs mutation
and FTD patients bearing the same mutation): voxel-
based morphometry (VBM, for structural grey and
white matter alterations) [19] and a series of func-
tional network connectivity measures. First of all,
we explored different brain functional networks by
independent component analysis (ICA), considering
the involvement of specific networks in FTD related
to GRN [20]. More recently, a number of functional
parameters has been used to study local properties of
brain activity at rest, also in FTD related to GRN,
like regional homogeneity (ReHo), to look at the
coherence of focal resting state fluctuations [21],
the fractional amplitude of low frequency fluctua-
tion (fALFF, that describes the power of the signal
in the low frequency range) [22], degree centrality
(DC, that allows the study of the nodes that form
the whole-brain network [23]), and the voxel homo-
topic connectivity (VMHC, as index of functional
symmetry in resting-state brain activity) [24]. In the
present work we have taken advantage of the mul-
tivariate approach as machine-learning classifier of
MVPA: 1) to identify the most accurate functional
and/or structural neuroimaging index to be used,
and 2) to define the most accurate neuroimaging
pattern to classify the different stages of the GRN
disease.
METHODS
Subjects
Subjects were recruited at the Centre for Ageing
Brain and Neurodegenerative Disorders, Univer-
sity of Brescia (Brescia, Italy). The studied sample
included 64 subjects, 14 were patients with FTD car-
rying GRN Thr272fs mutation (FTD-GRN+) and 16
of them were age and gender-matched healthy sub-
jects (old healthy controls, oHC). Furthermore, 17
asymptomatic carriers carrying GRN Thr272fs muta-
tion (aGRN+) and 17 non-carriers belonging to the
AU
TH
OR
 C
OP
Y
E. Premi et al. / Looking for Neuroimaging Markers in Frontotemporal Lobar Degeneration Clinical Trials 251
same families (young healthy controls, yHC) were
recruited (see Supplementary Figure 1).
FTD patients met current clinical diagnostic cri-
teria either for bvFTD (7 cases) or avPPA (7 cases)
[1, 2]. An extensive neuropsychological assessment
in both patients and asymptomatic siblings, includ-
ing the FTD-modified Clinical Dementia Rating scale
(FTD-modified CDR) was administered, as previ-
ously described [25].
Written informed consent from the subject or from
the responsible guardian if the subject was incapable,
was obtained, for each procedure, before study ini-
tiation, as well as for blood collection by venous
puncture, genetic analysis, and MRI scanning. The
research protocol was approved by the ethics com-
mittee of the Brescia Hospital. The work conformed
to the Helsinki Declaration.
Granulin sequencing
Genomic DNA was extracted from peripheral
blood using a standard procedure. All the 12 exons
plus exon 0 of GRN, and at least 30 base pairs (bp) of
their flanking introns were evaluated by polymerase
chain reaction (PCR) and subsequent sequencing.
GRN Thr272fs (g.1977 1980 delCACT) was tested
as described elsewhere [26].
MRI acquisition
All imaging was obtained using a 1.5T Siemens
Symphony magnetic resonance scanner (Siemens,
Erlangen, Germany), equipped with a circularly
polarized transmit-receive coil. In a single session,
the following scans were collected from each studied
subject: 1) Dual-echo turbo spin echo (TSE) (repe-
tition time [TR] = 2500 ms, echo time [TE] = 50 ms),
to exclude the presence of macroscopic brain
abnormalities, according to exclusion criteria; 2)
3D magnetization-prepared rapid gradient echo
(MPRAGE) T1-weighted scan (TR = 2010 ms, TE =
3.93 ms, matrix = 1 × 1 × 1, in-plane field of view
[FOV] = 250 × 250 mm2, slice thickness = 1 mm,
flip angle = 15◦); and (3) T2*-weighted echo planar
(EPI) sensitized to blood oxygen level dependent
(BOLD) contrast (TR = 2500 ms, TE = 50 ms, 29
axial slices parallel to anterior commisure–posterior
commissure line (AC-PC) line, matrix = 64 × 64,
field of view = 224 mm, slice thickness = 3.5 mm) for
resting state fMRI. Blood oxygen level dependent
EPI images were collected during rest for an 8-min
period, resulting in a total of 195 volumes. During
this acquisition, subjects were instructed to keep their
eyes closed, not to think of anything in particular,
and not to fall asleep.
MRI preprocessing
As previously described [16, 20], all prepro-
cessing steps were carried out using Advanced
Data Processing Assistant for resting-state fMRI
(DPARSFA) (http://rfmri.org/DPARSF) [27] which
is based on Resting-State fMRI Data Analysis
Toolkit (REST, http://www.restfmri.net) [28] and
Statistical Parametric Mapping (SPM8) (http://www.
fil.ion.ucl.ac.uk/spm). Grey matter (GM) and white
matter (WM) probability maps using SPM5 Uni-
fied Segmentation were calculated, applying a spatial
smoothing with an isotropic Gaussian kernel (full-
width at half-maximum (FWHM), 10 × 10 × 10 mm)
to reduce spatial noise. For resting state fMRI
analysis (ICA networks and local connectivity mea-
sures) all data were spatially normalized to the
T1 unified segmentation template in Montreal Neu-
rological Institute coordinates derived from SPM8
software and resampled to 3 × 3 × 3 cubic voxels.
For all considered measures, a spatial smoothing
(FWHM = 8 × 8 × 8 mm) was applied to reduce spa-
tial noise. ICA functional brain networks, i.e., the
salience (SN), the default mode (DMN), the fronto-
parietal (FPN), the dorsal attentional (DAN), the
executive (EN) networks were obtained. Moreover,
local connectivity network measures, i.e., ReHo,
ALFF, fALFF, DC, and VMHC, were computed. For
each subject, all the derived voxelwise whole-brain
maps (either structural (GM and WM) and functional
(ICA networks, ReHo, ALFF, fALFF, DC, VMHC))
were considered for MVPA analysis.
Dimensionality reduction
Before MVPA analysis we need a dimensionality
reduction of the data. The dimensionality problem,
i.e., the number of voxels greater than the number of
subjects, implies that the dataset is ill-conditioned,
thus, not guaranteeing the existence of a unique
solution. For this reason, we then reduced the compu-
tational complexity of the classification representing
the data in a space of smaller dimensionality. First, we
created a series of masks by performing t tests (T < 0,
p < 0.05 FDR corrected) between all neuroimaging
measures across participants within a classification
comparison (FTD-GRN+ and oHC; aGRN+ and
yHC). Then we used the singular value decompo-
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sition (SVD) to further reduce the dimensionality of
all the data [29]. The SVD seek for an orthogonal
basis that explained most of the variance of the data.
By projecting the original data on the principal com-
ponents, the set of correlated variables (voxels) were
transformed into a set of uncorrelated variables that
were a linear combination of the original variables.
Defining a N (subjects) × M (voxels) mean centered
matrix, the SVD searched the eigenvalues and eigen-
vectors of the (M × M) covariance matrix. Because
the number of voxels M exceeded the number of sub-
jects N, there were only N–1 significant eigenvectors.
The final results of the SVD is a matrix of dimension
N × N.
Multivoxel pattern analysis (MVPA)
MVPA has gained increasing interest because it
allows the detection of differences between condi-
tions by focusing on the analysis and comparison of
distributed spatial patterns of activity [30]. In order to
inspect if the different types of maps (i.e., structural
maps such as GM and WM probabilistic voxelwise
maps) as well as functional maps (i.e., ICA-based net-
work and local connectivity indexes) had statistically
significant discrimination capacity, we employed
a SVM approach [29]. This can be considered a
supervised classification problem where a classifier
attempts to capture the relationships between spatial
patterns of fMRI activity and experimental condi-
tions, assigning the fMRI activity of each subject to
one of several predefined conditions (for example,
FTD-GRN+ versus oHC) using a set of examples of
the same fMRI activity. To make this decision we
used the leave one out method with the experimental
data.
Classifier
To verify the existence of multivariate differences
in the studied comparisons (FTD-GRN+ versus oHC
and aGRN+ versus yHC) we treated each map as a
point in a multidimensional space (number of princi-
pal components), the result of the linear classification
was equivalent to search the hyperplane that separated
the two classes. This hyperplane was a linear function
that was able to separate the data defined as:
wT v + b = 0
where w is the weight vector, b was the intercept
(offset) and v the volumes projected on the principal
components. This hyperplane was learned during the
training phase, and corresponds to a decision func-
tion that can be used to classify the examples used in
the test phase. In our case, the algorithm used to find
the hyperplane of separation between the two classes
was the algorithm proposed by Boser et al. [31], also
known as SVM [29, 32]. The weight vectors and the
intercept determined the separation hyperplane. If the
samples were in the voxels space, the weight vector
w represented a volume with the most discriminant
regions. This means that given two classes that repre-
sent the two experimental conditions, a positive voxel
value indicates that the voxel has greater activity dur-
ing condition 1 compared to condition 2 in most of
training examples, and a negative voxel value indi-
cates more reduced activity in condition 1 compared
to condition 2. Since the classifier was multivariate in
nature, the combination of all discriminant voxels, as
a whole, was identified as a global activation pattern
in which the brain states differ. The absolute value of
each element of the map, obtained by discriminant
classifier, determined its importance.
Furthermore, it was possible to obtain a proba-
bilistic map of the most discriminative voxels. This
was done using a statistical non-parametric meth-
ods. This step tested the hypothesis that there was
no difference between the two brain states of the two
classes using a permutation test of the label of the
two classes and training the SVM with this permuta-
tion of labels. In this way, we estimated a probability
distribution of each voxel under the assumption that
there was no relationship between the label of the
class. We achieved a voxel level p statistic (propor-
tion of values in the distribution). For a given voxel,
if p was significantly small, then the voxel discrimi-
nates between the two classes. In this sense, positive
(increased, red to yellow) and negative (reduced, blue
to green) areas should not be strictly considered as an
absolute change of the studied parameter (for exam-
ple GM density), but only as areas with significantly
greater information to classify a subject as patients
(i.e., FTD-GRN+) or healthy controls (i.e., oHC).
Classifier performance
To evaluate the performance of the classifier, we
used a leave-one-subject-out cross validation test
[33], considered a valid approach with scarce data
[34]. In each learning phase, given the set of S sub-
jects, one example was left out and the S-1 remaining
examples were used as training set. After the learning
phase, in the test phase, the excluded subject was used
to assess the performance of the machine. This pro-
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cedure was repeated S times, once for each excluded
subject. The result was an average performance of
the different trained machines. Furthermore, for each
studied index (structural and functional) sensitivity
and specificity were defined. Finally, for each stud-
ied subject, misclassification (i.e. how many indexes
correctly classified that specific subject) was consid-
ered.
All calculations were made using the LIBSVM
library by Chang et al. [35] and in house developed
Matlab scripts.
Statistical analysis
SPSS package (v. 21.0, Chicago, IL, USA) was
employed to run statistics for group differences in
demographic and clinical characteristics. Group com-
parisons were assessed by Mann-Whitney test or χ2
test, setting the statistical threshold to p-values Bon-
ferroni’s corrected ≤0.05.
RESULTS
Demographic, clinical and neuropsychological
characteristics of the studies subjects were reported
in Table 1. See Supplementary Table 1 for the neu-
ropsychological evaluation of FTD-GRN+ patients.
We inspected whether the different anatomical
measures and the different patterns of functional
connectivity were able to classify the two patholog-
ical categories compared to healthy controls groups
(FTD-GRN+ versus oHC and aGRN+ versus yHC)
correctly. For each group, we calculated a series
of voxelwise anatomical (GM and WM) and func-
tional measures related to local connectivity (DC,
ALFF, fALFF, ReHo, VMHC) and to ICA networks
(SN, DMN, EN, FPN, DAN). Figure 1A showed a
graph depicting the classification performances and
the related table with the accuracy for each studied
measures; Fig. 1B reported, for each subject, the
number of measures with a correct classification
(true positive). Classification performance was sig-
nificantly lower in FTD-GRN+ compared to oHC
(8.9 ± 3.2 versus 11.4 ± 2.5, p = 0.025, Mann Whit-
ney U test). Interestingly, the four patients with the
smallest number of correct classifications (patient
1 = 6; patient 6 = 3; patient 11 = 6; patient 14 = 4)
were all affected by agrammatic variant of PPA. In
this sense, the inclusion of both clinical phenotypes
of GRN disease partially reduced homogeneity and
could explain the difference in classification perfor-
mances. No significant differences between aGRN+
and yHC (6.8 ± 2.0 versus 6.8 ± 1.5, p = 0.93, Mann
Whitney U test). Sensitivity and specificity for all the
studied measures are reported in Table 2. As expected,
the FTD-GRN+ versus oHC comparison showed bet-
ter classification performances than aGRN+ versus
yHC. GM atrophy (with left frontal, temporal, and
parietal pattern) raised the greatest values, correctly
classifying 96.5% of FTD-GRN+; even white matter
bundle alterations were good predictors of FTD-
GRN+ pathology, with the more discriminative tracts
localized in fronto-temporal regions (uncinate fasci-
culus, anterior commissure and inferior longitudinal
fasciculus). The high overlap between blue-green
areas (classifying for FTD-GRN+ group) and known
atrophic regions in FTD-GRN+ (in line with litera-
ture data) [4, 10], supported the concept that atrophic
regions in FTD-GRN+ contained the highest infor-
mation to correctly classify an FTD-GRN+ subject.
On the other hand, red-yellow areas should not be
considered as areas with “increased” GM density in
FTD-GRN+, but only as areas with the highest pre-
dictive value for oHC in MVPA analysis.
In regard to functional measures, all local connec-
tivity measures, such as DC, ALFF, fALFF, ReHo,
and VMHC showed good discrimination power in
identifying FTD-GRN+ (79.3–82.8%). Even with
Table 1
Clinical and demographic characteristics of included subjects
Variable FTD-GRN+ (n = 14) oHC (n = 16) aGRN+ (n = 17) yHC (n = 17) p
Age at evaluation, y 60.4 ± 5.3 59.7 ± 8.7 41.6 ± 9.0 36.3 ± 7.4 n.s.*
Age at onset, y 58.8 ± 6.2 – – –
Disease duration, y 1.93 ± 1.9 – – –
Gender, female % (n) 64.3 (9) 75.0 (12) 47.1 (8) 64.7 (11) n.s.∧
Family history, positive % (n) 85.7 (12) – 100 (17) –
Clinical phenotype, bvFTD % (n) 50.0 (7) – – –
Educational level, y 7.5 ± 2.6 9.1 ± 4.6 11.2 ± 3.8 11.6 ± 3.4 n.s.∗
FTD, frontotemporal dementia; FTD-GRN+, FTD patients carrying Granulin Thr272fs mutation; oHC, old healthy controls; aGRN+, asymp-
tomatic subjects carrying Granulin Thr272fs mutation; yHC, young healthy controls; FTD-CDR, frontotemporal dementia modified Clinical
Dementia Rating scale. ∗Mann-Whitney U test (FTD-GRN+ versus oHC and aGRN+ versus yHC); χ2 test (FTD-GRN+ versus oHC and
aGRN+ versus yHC). ∧For all analyses, we considered a statistical threshold of p Bonferroni’s corrected ≤0.05.
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Fig. 1. A) Radar chart showing the classification results (discriminative power) of the different structural and functional measures. The green
ring represents the significant (>55% of right classification) performance for each measure. Blue line is for FTD-GRN+ versus oHC and red
line is for aGRN+ versus yHC. On the right, a table with the discriminative power (accuracy) of each studied measure is reported. B) Bar
graphs with the number of measures with a correct classification (true positive) for each studied subject, considering FTD-GRN+ versus
oHC (blue) and aGRN+ versus yHC (red); the overall number of measures was 15. FTD-GRN+, frontotemporal dementia carrying Granulin
mutation; aGRN+, asymptomatic carriers of Granulin mutation; oHC, old healthy controls; yHC, young healthy controls; GM, grey matter;
WM, white matter; VBM, voxel based morphometry; SN, salience network; DMN, default mode network; FPN, fronto-parietal network;
DAN, dorsal attentional network; EN, executive network; ReHo, regional homogeneity; ALFF, amplitude of low frequency fluctuations;
fALFF: fractional amplitude of low frequency fluctuations; DC, degree centrality; VMHC, voxel-mirrored homotopic connectivity.
some slight differences among measures, the best dis-
criminative pattern for local connectivity indexes was
characterized by a reduced connectivity in the frontal,
temporal, and parietal regions with a concomitant
increased connectivity in the surrounding regions
(Fig. 2). Considering ICA networks, ventral SN and
AU
TH
OR
 C
OP
Y
E. Premi et al. / Looking for Neuroimaging Markers in Frontotemporal Lobar Degeneration Clinical Trials 255
Table 2
Standard deviation, sensitivity and specificity of classifier performances across the leave-one-out
validation in the studied groups and imaging modalities
FTD-GRN+ versus oHC aGRN+ versus yHC
SD Sensitivity Specificity SD Sensitivity Specificity
GM (VBM) 4.9 0.86 0.99 6.1 0.23 0.41
WM (VBM) 6.3 0.78 0.87 9.9 0.52 0.52
ALFF 7.6 0.5 0.75 5.7 0.41 0.29
fALFF 4.7 0.71 0.75 8.6 0.76 0.52
DC 9.7 0.78 0.87 6.8 0.58 0.58
ReHo 3.6 0.71 0.93 6.3 0.41 0.47
VMHC 5.4 0.43 0.93 6.4 0.35 0.52
DAN 7.7 0.71 0.68 10.9 0.35 0.41
DMN anterior 7.2 0.71 0.68 4.9 0.35 0.29
DMN posterior 5.6 0.42 0.75 5.9 0.35 0.35
EN 5.2 0.28 0.5 10.4 0.47 0.47
FPN right 5 0.28 0.37 7.2 0.64 0.58
FPN left 7.3 0.64 0.68 5.3 0.29 0.35
SN dorsal 7.1 0.28 0.62 10.8 0.41 0.41
SN ventral 5.7 0.64 0.93 4.1 0.52 0.52
FTD-GRN+, frontotemporal dementia carryingGranulinmutation; aGRN+, asymptomatic carriers ofGranulin
mutation; oHC, old healthy controls; yHC, young healthy controls; SD, standard deviation; GM, grey matter;
WM, white matter; VBM, voxel-based morphometry; ALFF, amplitude of low frequency fluctuations; fALFF,
fractional amplitude of low frequency fluctuations; DC, degree centrality; ReHo, regional homogeneity; VMHC,
voxel-mirrored homotopic connectivity; DAN, dorsal attentional network; DMN, default mode network; EN,
executive network; FPN, fronto-parietal network; SN, salience network.
left FPN showed the highest classification perfor-
mances between FTD-GRN+versus oHC (82.8% and
75.9%), with a spatial pattern of frontal-temporal and
parietal reduction, with areas of increased connectiv-
ity in left frontal cortex (left FPN).
In aGRN+, structural indexes (GM and WM
density) were not able to classify aGRN+ sub-
jects (GM: 39.4% and WM: 57.5%). Otherwise,
the best classification performances were obtained
by functional measures (fALFF: accuracy: 84.8%,
sensitivity: 76%, specificity: 52%; and DC; accu-
racy: 72.7%, sensitivity: 58%, specificity: 58%). The
best discriminative pattern for local connectivity
indexes presented a reduced connectivity in poste-
rior regions and increased connectivity in prefrontal
regions (Fig. 3). ICA networks presented an overall
low discrimination power, with the best performances
for the right FPN, EN and ventral SN (66.7%, 66.7%
and 63.6%) (Figs. 1 and 3). A high spatial concor-
dance between ventral SN and right FPN was evident
especially in the inferior frontal regions; otherwise,
EN presented a pattern of increased connectivity in
prefrontal regions, accordingly with local connectiv-
ity findings (Figs. 1 and 3).
As summarized in Fig. 4 (overlap of classifica-
tion areas across all the measures here employed
between FTD-GRN+ versus oHC (Fig. 4A) and
aGRN+ versus yHC (Fig. 4B)), the best predictive
measure to distinguish FTD-GRN+ from oHC was
VBM GM density, with the more discriminative pat-
tern involving frontal-temporal and parietal regions
(and, in particular, left frontal and parietal among
all, by areas). Conversely, aGRN+ group was better
classified by local connectivity measures (especially
fALFF) with a discrimination pattern characterized
by a widespread connectivity decrease in parietal
and posterior associative areas, with a well-structured
increased connectivity in prefrontal regions. Espe-
cially for aGRN+ and in line with literature data
[16, 20, 36], the concept that red-yellow areas could
be considered as increased connectivity was more
plausible. Finally, fALFF index was the only mea-
sure with high (>80%) discriminative power in both
comparisons (FTD-GRN+ versus oHC and aGRN+
versus yHC).
DISCUSSION
In the last years, considerable steps forward in the
knowledge of the pathogenesis of FTD have been
made [7, 37], principally based on the identification
of neuropathological inclusions and inherited deter-
minants of the disease [38–40]. In this sense, the
study of the monogenic forms of FTLD, such asGRN,
MAPT orC9orf72 [41, 42], represents the ideal exper-
imental model to define markers related to a specific
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Fig. 2. Significant anatomical, voxelwise functional and network-related discriminative patterns for the FTD-GRN+ versus oHC. Blue to
green are areas with “reduced” activity that predict for FTD-GRN+, red to yellow are areas with “increased” activity that predicts for
FTD-GRN+. All significant results are superimposed on a 3D T1 MRI anatomical template. FTD-GRN+, frontotemporal dementia carrying
Granulin mutation; aGRN+, asymptomatic carriers of Granulin mutation; oHC, old healthy controls; yHC, young healthy controls; GM, grey
matter; WM, white matter; VBM, voxel based morphometry; SN, salience network; DMN, default mode network; FPN, fronto-parietal net-
work; DAN, dorsal attentional network; EN, executive network; ReHo, regional homogeneity; ALFF, amplitude of low frequency fluctuations;
fALFF: fractional amplitude of low frequency fluctuations; DC, degree centrality; VMHC, voxel-mirrored homotopic connectivity.
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Fig. 3. Significant anatomical, voxelwise functional and network-related discriminative patterns for the aGRN+ group versus yHC. Blue to
green are areas with “reduced” activity that predicts for aGRN+, red to yellow are areas with “increased” activity that predicts for aGRN+.
All significant results are superimposed on a 3D T1 MRI anatomical template. aGRN+, asymptomatic carriers of Granulin mutation; oHC,
old healthy controls; yHC, young healthy controls; SN, salience network; DMN, default mode network; FPN, fronto-parietal network; DAN,
dorsal attentional network; EN, executive network; ReHo, regional homogeneity; ALFF, amplitude of low frequency fluctuations; fALFF:
fractional amplitude of low frequency fluctuations; DC, degree centrality; VMHC, voxel-mirrored homotopic connectivity.
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Fig. 4. Probabilistic maps with the areas with the highest cumulative predictive weights for all the measures. A) FTD-GRN+. B) aGRN+.
Blue to green are areas with “reduced” activity that predict for the pathological sample, red to yellow are areas with “increased” activity that
predict for the pathological sample. These images shows the spatial overlap of the predictive patterns relative to the different measures here
employed. Results are superimposed on 3D T1 MRI template. FTD-GRN+, frontotemporal dementia carrying Granulin mutation; aGRN+,
asymptomatic carriers of Granulin mutation.
molecular pathway [6, 17, 43]. GRN mutations lead
to a homogeneous FTD-TDP pathology and give the
opportunity to unravel FTD from asymptomatic to
symptomatic stages [17, 20, 44]. The definition of sur-
rogate endpoints will be mandatory to test the efficacy
of future pharmacological treatments [17].
MRI represents one of the most powerful tools
to study in vivo neurodegenerative disorders, with a
wide range of possible sequences, and to explore in
depth brain functional and structural abnormalities
[17, 45]. However, in FTD spectrum, and in GRN
disease in particular, it is still unknown which target
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brain patterns might be the most sensitive to capture
the ongoing neuropathological process in both pre-
symptomatic and symptomatic disease phases, and
which MRI technique should be used to achieve the
best accuracy. In the present work, we took advan-
tage of MVPA to concomitantly assess the utility of a
series of MRI data in a cohort of GRN Thr272fs carri-
ers, in their presymptomatic and symptomatic stages
of the disease. The herein SVM approach was able
to identify the optimal separation hyperplane (best
accuracy) that maximized the separation between two
given classes (i.e., FTD-GRN+ versus oHC or aGRN+
versus yHC), using either structural measures, such as
grey and white matter density, and resting-state fMRI
functional connectivity maps (such as functional net-
works or/and local connectivity maps). This allowed
us to define which technique was the most useful in
detecting significant differences between groups and
to identify the global pattern (rather than the signif-
icant clusters for the univariate approach) that best
characterized and subsequently classified GRN car-
riers as compared to controls. In line with previous
literature data, structural alterations were the most
predictive measures when disease is overt, due to the
neuronal loss and the disruption of white matter bun-
dles [8, 17]. In this stage, we even found functional
connectivity measure abnormalities, demonstrating
both large-scale network disconnections and local
within-network coherence hypoconnectivity [46, 47].
Overall, in symptomatic GRN mutation carriers, the
brain damage was detected in the frontal, temporal
and parietal regions, with a predominant involvement
of left frontal and parietal areas. Furthermore, we
were able to demonstrate that: 1) other functional
networks beyond SN were involved in the clinical
phase of FTD-GRN+ and 2) the best discriminative
spatial pattern (for each of the studied measures)
was characterized by areas of reduced connectiv-
ity as well as of increased connectivity, the latter
with a potential compensatory role [20, 46]. Finally,
local connectivity metrics supported the idea of a
long-distance functional impairment coupled with
grey matter atrophy in frontal, temporal and parietal
regions.
Conversely, in the preclinical phase, structural
changes were not able to identify GRN carriers
accurately, while resting-state functional connec-
tivity measures did. As compared to the results
of the Genetic Fronto-temporal dementia Initiative
(GENFI) study [17], we were not able to find any
significant structural alteration in our sample of
asymptomatic GRN carriers. This was probably due
to the small sample size (n = 17) and to the mean
age of our group, up to 10 years younger than that
in GENFI study [17]. In our work, we found that
local connectivity indexes, such as fALFF and DC,
showed better classification performances than ICA
networks measures. These local connectivity metrics
captured the subtle perturbations of the local inte-
gration of the signal (namely focusing on the power
of the signal as the sum of amplitudes in the low
frequency oscillations, fALFF) [22], and the node
characteristics that make a node “central” within a
network, by counting the number of direct connec-
tions from each node to all others (DC) [23]. These
abnormalities were indeed able not only to detect
the alterations of a single network, but the impair-
ment of the inter-correlation among the involved
networks [48]. Interestingly, recent electrophysiolog-
ical studies suggested that functional connectivity
perturbation might be modulated, and might rep-
resent a target and a marker of disease-modifying
therapies [49].
These data suggest that the early alterations in
aGRN+ are represented by cumulative decreases
in areas belonging to fronto-parietal regions with
increased functional connectivity in prefrontal areas,
measured by all local connectivity metrics and EN
network. This was in line with our previous findings
in GRN-related disease [9, 16, 20], demonstrating
an impaired resting state functional connectivity in
posterior regions as well as an increased (potentially
compensatory) connectivity in prefrontal regions
[50], in accordance with the concept of molecular
nexopathies proposed by Warren et al. [51]. In this
sense, in line with GENFI study [17], GRN disease is
characterized by a progressive fronto-parietal impair-
ment moving from preclinical to clinical stages,
representing the pathological spreading of the disease
following long-distance white matter bundles [51].
On the other hand, regions (i.e., prefrontal cortex)
with a different profile of functional alteration during
the GRN disease course, could reflect the complexity
of brain dynamic interaction, with some regions with
increased activity as compensatory effort towards
damaged at-distance regions.
Our work argued for the usefulness of MVPA in
identifying the most accurate neuroimaging marker
for clinical trials in GRN-related disease, suggesting
that functional connectivity metrics (i.e., local con-
nectivity indexes) were the most accurate measures
in preclinical phases, while structural (i.e., grey and
white matter) alterations were the best tools when
disease is overt. Furthermore, the best local connec-
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tivity measure (fALFF) in aGRN+ showed also high
performances (total accuracy >80%) in discriminat-
ing FTD-GRN+ versus healthy controls. In this sense,
throughout the application of MVPA, fALFF could be
considered the best MRI marker in the GRN disease
continuum. From this point of view, MVPA could
be of help in describing the neuroimaging pattern of
each stage of GRN disease: 1) an asymmetric pattern
of frontal, temporal and parietal atrophy with a com-
plex involvement of many functional brain networks
in FTD-GRN+; and 2) a predominant involvement of
functional brain networks, with a not well organized
reduced connectivity in posterior regions associated
with a high-structured increased activity in prefrontal
regions in aGRN+.
However, our study presented several significant
limitations. First of all, the cross-sectional evaluation
of our samples (FTD-GRN+ and aGRN+) did not
allow a complete understanding of the complex mod-
ulation of brain damage, especially for resting state
fMRI parameters. In this sense, multicenter longitu-
dinal studies on genetically-defined populations are
mandatory, in line with the aim of GENFI [17]. A
further limitation, the sample size in the FTD-GRN+
group (16 patients, 8 bvFTD and 8 avPPA) did not
allow a further evaluation of the functional and struc-
tural parameters of GRN mutation in the different
clinical phenotypes; furthermore, as demonstrated by
the analysis of the number of correct classifications
for each subjects, in FTD-GRN+ the subject with
the lowest number of correct classifications belonged
to agrammatic variant of PPA, suggesting a par-
tial inhomogeneity in FTD-GRN+ group. Moreover,
nuisance variables inclusion in MVPA approach is
not completely standardized, with multivariate anal-
ysis not controlled for age and education effects.
Finally, despite high values of total accuracy, sen-
sibility is approximately 70% and specificity 50%.
In this regard, it is important to note that SVM was
not originally defined to search for the best combi-
nation of sensitivity and specificity (like in receiver
operating characteristic curve) but to define the best
discrimination between two condition (or classes)
[52]. Furthermore, in our work poor specificity could
be primary due to a higher variability in yHC com-
pared to aGRN+, considering the small sample size
of the studied group. Considering SVM theoretical
approach, this technique is optimized for groups with
similar (or better identical) size, making the analy-
sis of imbalanced groups problematic [52]. All these
considerations partially weakening a direct clinical
application of each single MRI index alone, support-
ing the idea of a global classifier to apply all the
studied indexes at the same time.
Further studies are needed: 1) to simultaneously
integrate all the aforementioned measures in a classi-
fier able to trace the disease progression (increasing
total accuracy, sensibility and specificity) moving
from preclinical to clinical stage of the disease and
2) to integrate neuroimaging and biological mark-
ers in a multivariate statistical design ameliorating
classification performances in GRN-related disease
in monogenic and sporadic dementias. Furthermore,
multivariate techniques like MVPA could be of
interest in international multicenter study on GRN
mutation as well as for other causative mutations for
FTLD (MAPT, C9orf72).
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